复方血栓通胶囊用于非增殖期糖尿病视网膜病变的疗效观察

2016-10-19朱艳霞

中国现代医生 2016年24期

关键词：糖尿病

朱艳霞　李　俊　应　佳

浙江省丽水市中心医院眼科，浙江丽水323000

复方血栓通胶囊用于非增殖期糖尿病视网膜病变的疗效观察

朱艳霞李俊应佳

浙江省丽水市中心医院眼科，浙江丽水323000

目的探讨复方血栓通胶囊用于非增殖期糖尿病视网膜病变（NPDR）患者的临床疗效。方法选择2015年2月～2016年2月期间收治的96例NPDR患者资料，分为观察组与对照组，对照组予常规降糖治疗，观察组在常规降糖治疗的基础上予复方血栓通胶囊治疗。观察两组患者视网膜微循环及视力改善情况。结果观察组治疗后患者视力改善情况优于对照组，组间比较差异有统计学意义（P＜0.05）；观察组治疗后患者CRA和CRV血液动力学参数优于对照组，组间比较差异有统计学意义（P＜0.05）。结论复方血栓通胶囊可改善NPDR患者视网膜血流动力学指标，提高视力。

非增殖期糖尿病视网膜病变曰复方血栓通胶囊曰视网膜曰微循环

[Abstract]Objective To discuss the efficacy of compound Xueshuantong capsules for non-proliferative diabetic retinopathy patients（NPDR）.Methods A total of 96 NPDR patients treated in our hospital were divided into observation group and control group from February 2015 to February 2016.The control group was treated with the conventional therapy. On thebasis ofconventional treatment，the observation group was treated with compound Xueshuantong capsules. Retina microcirculation and vision improvement were observed between the two groups.Results The observation group was better than the control group in the improvement of vision after treatment，and the difference between the two groups was statistically significant（P＜0.05）.The observation group was superior to the control group in terms of hemadynamical parameters CRA and CRV after treatment（P＜0.05）.Conclusion The compound Xueshuantong capsules can improve hemadynamical parameters of retina for NPDR patients and improre their vision.

[Key words]Non-proliferative diabetic retinopathy；Compound Xueshuantong capsule；Retina；Microcirculation

糖尿病（diabetes mellitus，DM）是临床常见的内分泌代谢性疾病，DM微血管并发症中以糖尿病视网膜病变（diabetic retinopathy，DR）最为常见［1］。DR是一种特异性、致盲性眼病，临床根据DR患者视网膜新生血管情况，将其分为非增殖性糖尿病视网膜病变（non-proliferative diabeticretinopathy，NPDR）和增殖性糖尿病视网膜病变。NPDR是指视网膜未形成新生血管的DR，可引起一系列眼科病症，严重者可致盲［2］。因此，NPDR的治疗及预后是临床的重点课题。近年来我院对收治的NPDR患者予血栓通胶囊辅助治疗，疗效显著，现报道如下。